We are live on ! Find out more
CSII

Cardiovascular Systems, Inc.

Delisted

CSII was delisted on the 27th of April, 2023.

157 hedge funds and large institutions have $813M invested in Cardiovascular Systems, Inc. in 2017 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 61 increasing their positions, 52 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

18% more capital invested

Capital invested by funds: $689M → $813M (+$123M)

17% more repeat investments, than reductions

Existing positions increased: 61 | Existing positions reduced: 52

2% more call options, than puts

Call options by funds: $603K | Put options by funds: $590K

6% less funds holding

Funds holding: 167157 (-10)

42% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 24

Holders
157
Holders Change
-10
Holders Change %
-5.99%
% of All Funds
3.91%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
14
Increased
61
Reduced
52
Closed
24
Calls
$603K
Puts
$590K
Net Calls
+$13K
Net Calls Change
+$440K
Name Holding Trade Value Shares
Change
Change in
Stake
JP Morgan Chase
126
JP Morgan Chase
New York
$265K +$64.5K +2,115 +35%
AG
127
Advisor Group
Arizona
$263K +$1.07K +35 +0.4%
PCM
128
Prelude Capital Management
New York
$252K +$13.4K +439 +6%
Arrowstreet Capital
129
Arrowstreet Capital
Massachusetts
$251K -$1.38M -45,442 -85%
FMT
130
First Mercantile Trust
Tennessee
$251K -$83.7K -2,746 -26%
Legal & General Group
131
Legal & General Group
United Kingdom
$249K +$6.58K +216 +3%
WPC
132
White Pine Capital
Minnesota
$248K
Barclays
133
Barclays
United Kingdom
$233K -$347K -11,390 -61%
QI
134
Quotient Investors
New York
$226K -$387K -12,700 -64%
WEC
135
Winslow Evans & Crocker
Massachusetts
$210K +$35K +1,150 +21%
BCM
136
BlueCrest Capital Management
Jersey
$204K +$193K +6,339 New
PIM
137
Partner Investment Management
California
$194K -$100K -3,281 -35%
BNP Paribas Financial Markets
138
BNP Paribas Financial Markets
France
$166K +$96.5K +3,165 +161%
CSS
139
Cubist Systematic Strategies
Connecticut
$142K -$104K -3,411 -44%
Canada Life
140
Canada Life
Manitoba, Canada
$103K
AIP
141
Ameritas Investment Partners
Nebraska
$90K +$9.9K +325 +13%
Zurich Cantonal Bank
142
Zurich Cantonal Bank
Switzerland
$66K
CCMW
143
Cypress Capital Management (Wyoming)
Wyoming
$51.6K -$138K -4,525 -74%
JIR
144
James Investment Research
Ohio
$51K
AIM
145
Acrospire Investment Management
Illinois
$41K -$91.4K -3,000 -70%
Creative Planning
146
Creative Planning
Kansas
$39K
Nisa Investment Advisors
147
Nisa Investment Advisors
Missouri
$30K +$15.2K +500 +119%
Envestnet Asset Management
148
Envestnet Asset Management
Illinois
$10K
SPIA
149
Steward Partners Investment Advisory
New York
$9K +$9.14K +300 New
Citigroup
150
Citigroup
New York
$7K -$19K -622 -75%

CSII Hedge Fund Activity: Q2 2017 in Review

157 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Cardiovascular Systems, Inc. (CSII) for Q2 2017, worth a combined $813M — up 18% from $689M a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of CSII and 14 opened new positions — a net loss of 10 holders — while 52 trimmed existing stakes and 61 added.

The largest buyer was Brown Capital Management, adding an estimated $67M. The largest seller was Camber Capital Management, exiting entirely with an estimated $49.5M sold.

  • 157 institutional investors held Cardiovascular Systems, Inc. (CSII) as of Q2 2017, down from 167 in Q1 2017.
  • Funds reported $813M of Cardiovascular Systems, Inc. stock for Q2 2017, up 18% quarter-over-quarter.
  • 14 funds opened new Cardiovascular Systems, Inc. positions in Q2 2017 and 24 closed out, a net change of -10 holders.
  • The largest Cardiovascular Systems, Inc. buyer in Q2 2017 was Brown Capital Management, an estimated $67M added.
  • The largest Cardiovascular Systems, Inc. seller in Q2 2017 was Camber Capital Management, an estimated $49.5M sold.

Based on aggregated 13F filings for Q2 2017.